Musculoskeletal Diseases: News and Research on Polymyalgia Rheumatica

MeSH tree: C05.799.720

Sarilumab beneficial for polymyalgia rheumatica patients

For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficacious for achieving ...

Oct 5, 2023

0

33

JAK signaling may be behind polymyalgia rheumatica

Janus tyrosine kinase (JAK) signaling may be involved in the pathogenesis of polymyalgia rheumatica (PMR), and tofacitinib may be an effective treatment, according to a pilot study published online June 29 in PLOS Medicine.

Jul 10, 2023

0

39